
Early-stage venture firm investing in cryptocurrency, blockchain and decentralised finance

A US venture firm providing pre-seed and seed capital to voice and conversational AI startups

Project Voice Capital Partners provides pre-seed and seed capital to early-stage startups working on conversational AI, including voice, audio, text and chat technologies. The firm is led by Bradley Metrock, who hosted the podcast This Week In Voice for nine seasons between 2017 and 2023, writes a related newsletter, and organises an invitation-only conference on conversational AI in the United States, and Marc Ladin, who has invested in the conversational AI space for several years. Its venture partners include Adam Cheyer, a co-founder of Apple's Siri and Samsung's Bixby who has also been involved with Change.org and Sentient Technologies, along with technical advisor Neil Jacobstein. The firm was raising capital for a dedicated voice AI fund, PVCP Vox, planned to launch in partnership with AngelList in January 2026.
Summary written by TrustList from the business's own published information, Sep 2026.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Project Voice Capital Partners.
Similar listings buyers compare against this one.

Early-stage venture firm investing in cryptocurrency, blockchain and decentralised finance

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Open-source blockchain with its own digital currency, digital assets, smart contracts and secure authentication

Multi-stage investor in AI, cyber and deep technology with offices in the US and Europe

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Seattle venture firm investing in cancer biotechnology and established technology companies

An early-stage venture fund known among founders for its network and hands-on support

Johnson & Johnson's innovation arm partnering with and investing in early-stage life science ventures
Everything here links back to the same verified catalogue. Pick your next stop.